Skip to content
★ Sign in to follow
TH

Thomas H. Morgan

Executive
Total declarations
12
Company
1
▲ Purchases (3 ops.)
€4,454
▼ Sales (9 ops.)
€691k

Latest filing published 11 May 2016 for BioCardia, Inc., €662k.

Insider track record

Disclosed buys
3
Disclosed sells
9
Signal history

No signal scores available.

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+37.5%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 Jun 2011 · 5613 days ago · €801
    -12.5%
    Entry US$129.60 · Close at T+365 US$113.40
  • Filed 23 May 2011 · 5649 days ago · €3,630
    -12.5%
    Entry US$129.60 · Close at T+365 US$113.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Thomas H. Morgan: trading record in brief

Thomas H. Morgan discloses dealings in BioCardia, Inc. to SEC (Form 4). The record holds 12 filings, for trades running from 10 May 2011 to 10 May 2016.

On the open market, the record shows 3 purchases worth €4,454 and 9 sales worth €691k. Netting one side against the other leaves €687k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2016, the count stands at no purchases and 1 sale.

A typical purchase (the median) is worth €801.

The latest filing, published on 11 May 2016, reports an open-market sale of €662k in BioCardia, Inc. The most recent open-market purchase was published on 14 May 2012, 5,292 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Thomas H. Morgan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ▼
    DirectorExecutivesBioCardia, Inc.
    753,100 USD37SEC
    7,531,004 shares@ US$0.10100.0% of flowCommon StockSEC:0001209191-16-119177:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    5,160 USD0SEC
    43,000 shares@ US$0.12Common StockSEC:0001209191-13-057116:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    10,962 USD0SEC
    91,350 shares@ US$0.12Common StockSEC:0001209191-13-055098:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    936 USD0SEC
    7,800 shares@ US$0.12Common StockSEC:0001209191-13-052517:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    1,300 USD0SEC
    10,000 shares@ US$0.13Common StockSEC:0001209191-13-051712:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    4,083 USD0SEC
    34,000 shares@ US$0.1201Common StockSEC:0001209191-13-051712:1
  • ▼
    DirectorExecutivesBioCardia, Inc.
    9,565 USD0SEC
    73,462 shares@ US$0.1302Common StockSEC:0001209191-13-050784:0
  • ▼
    DirectorExecutivesBioCardia, Inc.
    3,850 USD0SEC
    35,000 shares@ US$0.11Common StockSEC:0001209191-13-050784:1
  • ▼
    DirectorExecutivesBioCardia, Inc.
    3,600 USD0SEC
    30,000 shares@ US$0.12Common StockSEC:0001209191-13-050784:2
  • ▲
    DirectorExecutivesBioCardia, Inc.
    33 USD0SEC
    500 shares@ US$0.065Common Stock, par value $0.001 per shareSEC:0001209191-12-027880:0
    Canonical exit: 8 Aug 2011 (T+90)
  • ▲
    DirectorExecutivesBioCardia, Inc.
    1,138 USD0SEC
    22,750 shares@ US$0.05Common Stock, par value $0.001 per shareSEC:0001209191-11-036614:0
    Canonical exit: 14 Sept 2011 (T+90)
  • ▲
    DirectorExecutivesBioCardia, Inc.
    5,197 USD0SEC
    103,935 shares@ US$0.05Common Stock, par value $0.001 per shareSEC:0001209191-11-030549:0
    Canonical exit: 17 Aug 2011 (T+90)

12 of 12 declarations